Loading...
Open8.7
High8.77
Low8.58
Vol11.80M
P/EN/A
Mkt cap10.20B
52W H13.55
52W L6.85
Avg Vol16.06M
Div yield5.52%
Beta0.892
EPS-3.18
Loading...
See More Data from Yahoo Finance
PR Newswire - 20 hours agoViatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast ConditionsCNW Group - 6 days agoViatris Announces Launch of First Clozapine Orally Disintegrating Tablet (ODT) in CanadaMT Newswires - 11 days agoPiper Sandler Adjusts Price Target on Viatris to $9 From $10, Maintains Neutral Rating